By: Adam Eckert
Crinetics Pharmaceuticals shares are trading higher in Monday's after-hours session after the company announced it will be acquired by Vertex.


Adam Eckert is a Managing Editor at WIIM and a staff writer at Benzinga. Based in Indianapolis, he covers a range of topics including finance, trading, and technology, with a particular focus on financial platforms and trading technology. His work has been featured in notable publications such as Yahoo Finance, Business Insider, and Zenger News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Adam Eckert's coverage heavily leans towards investment analysis and cites data frequently. He seems to be interested in stock market movements, particularly those of technology companies and healthcare/pharmaceutical firms. When reaching out to him, consider providing expert insights or analyses on stock performance, IPOs, and the latest trends in these sectors.
Given his focus on citing data and investment analysis, he may also be receptive to pitches that provide unique datasets or offer statistical analysis related to stock market trends or specific industry performances.
Although Adam doesn't specify a geographic focus, it would be beneficial for potential sources to offer global perspectives within the technology companies and healthcare industries when pitching relevant stories.
This information evolves through artificial intelligence and human feedback. Improve this profile .